Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study

Yau, T.; Hsu, C.; Kang, Y.; Kim, T.; Hou, M.; Lim, H.; Chao, Y.; Kim, Y.; Ikeda, M.; Choo, S.; Neely, J.; Shen, Y.; Tschaika, M.; Kudo, M.

doi:10.1016/j.annonc.2020.04.058

Detailed Information

Cited 0 time in webofscience

Cited 0 time in scopus

Metadata Downloads

Efficacy and safety of nivolumab plus ipilimumab in Asian patients with advanced hepatocellular carcinoma: Subanalysis of the CheckMate 040 study

Authors: Yau, T.; Hsu, C.; Kang, Y.; Kim, T.; Hou, M.; Lim, H.; Chao, Y.; Kim, Y.; Ikeda, M.; Choo, S.; Neely, J.; Shen, Y.; Tschaika, M.; Kudo, M.

Issue Date: 202007

URI: https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/43492

DOI: 10.1016/j.annonc.2020.04.058

Conference Name: ANNALS OF ONCOLOGY

Place: 네델란드
ELECTR NETWORK

Conference Name: ESMO 22nd World Congress on Gastrointestinal Cancer 2020

ISSN: 0923-7534
1569-8041

Files in This Item: There are no files associated with this item.

Appears in Collections: 2. Clinical Science > Department of Medical Oncology and Hematology > 2. Conference Papers

Show full item record

qrcode

Altmetrics

Total Views & Downloads

STATISTICS: Total View :12,880,941; Today View :5,885

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Altmetrics

Total Views & Downloads

BROWSE